Journal of the American Heart Association Template
Write in a clean editor, then format for Journal of the American Heart Association in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Journal of the American Heart Association format
Journal of the American Heart Association is a peer-reviewed journal published by Wiley, covering Cardiovascular Function and Risk Factors, Atrial Fibrillation Management and Outcomes, Acute Myocardial Infarction Research.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of the American Heart Association 12 (3): 45–58.
Formats any DOI in Journal of the American Heart Association style. No sign-up. |
| Publishes research in | Cardiovascular Function and Risk Factors Atrial Fibrillation Management and Outcomes Acute Myocardial Infarction Research Cardiac Imaging and Diagnostics Heart Failure Treatment and Management |
| ISSN | 2047-9980 |
| Citation impact (2-yr) | 5.17 |
| h-index | 197 |
| i10-index | 7,714 |
| Total citations | 397,154 |
| Article processing charge | $2,750 |
| Open access | Yes |
| Top institutions publishing here | Harvard University |
| Journal website | www.ahajournals.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Journal of the American Heart Association per year
Citation impact of Journal of the American Heart Association by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of the American Heart Association
BACKGROUND: Tools for the prediction of atrial fibrillation (AF) may identify high-risk individuals more likely to benefit from preventive interventions and serve as a benchmark to test novel putative risk factors. METHODS AND RESULTS: Individual-level data from 3 large cohorts in the United States (Atherosclerosis Risk in Communities [ARIC] study, the Cardiovascular Health Study [CHS],…
BACKGROUND: The choline-derived metabolite trimethylamine N-oxide (TMAO) has been demonstrated to contribute to atherosclerosis and is associated with coronary artery disease risk. METHODS AND RESULTS: We explored the impact of TMAO on endothelial and smooth muscle cell function in vivo, focusing on disease-relevant outcomes for atherogenesis. Initially, we observed that aortas of LDLR(-/-) mice fed…
BACKGROUND: Gut microbiota has been suggested to play a role in almost all major diseases including cardio- and cerebrovascular diseases. A possible mechanism is the transformation of dietary choline and l-carnitine into trimethylamine by gut bacteria. This metabolite is further oxidized into trimethylamine-N-oxide (TMAO) in liver and promotes atherogenesis. Nevertheless, little is known about gut…
Direct oral anticoagulants (DOACs) have quickly become attractive alternatives to the long-standing standard of care in anticoagulation, vitamin K antagonist. DOACs are indicated for prevention and treatment of several cardiovascular conditions. Since the first approval in 2010, DOACs have emerged as leading therapeutic alternatives that provide both clinicians and patients with more effective, safe, and…